Gene Query: MRPL15

Dataset Description Geneva Score
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 33.54
A transcriptome-wide divergence in protein translation scales with LIN28B expression 29.27
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 27.48
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 22.79
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 22.79
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 21.07
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 20.3
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 20.25
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 20.25
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 20.18
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 17.62
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 16.71
RNAseq of HEK293 cells after Chtop knockdown 15.92
Co-transcriptional loading of RNA export factors shapes the human transcriptome 15.92
Rorc disruption in human FG pancreatic cancer cells 15.87
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 15.79
A549 cells and MSR-A549 cells 15.66
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 15.66
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 15.48
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 15.1
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 15.01
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 14.83
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 14.79
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 14.79
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 14.27
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 14.27
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 14.02
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 14.02
Genome-wide transcriptional response to random aneuploidy in human cells 13.76
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 13.44
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 12.61
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 12.61
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 12.44
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 12.44
LNCaP treated with iBET 12.3
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 12.17
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 12.08
Total RNA-seq in ALL-SIL upon JQ1 inhibition 11.97
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 11.9
Tracking of dCas9-methyltransferase footprints 11.66
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 11.54
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 11.54
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 11.32
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 11.23
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 10.95
RNA-seq in transgenic cells 10.86
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 10.84
Seletive inhibition of CDK9 in DLBCL cell lines 10.64
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 10.56
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 10.55
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 10.52
Regulation of protein translation during mitosis 10.4
NRDE2 negatively regulates nuclear exosome functions 10.32
Trans-differentiation of human adult peripheral blood T cells into neurons 10.19
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 10.0
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 9.95
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 9.89
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 9.88
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 9.88
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 9.87
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 9.83
KLF6-dependent transcription in renal cancer cells 9.82
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 9.79
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 9.69
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 9.66
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 9.65
Identification of Sin3B regulated genes during quiescence 9.62
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 9.6
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 9.6
RNA-seq of YB5 cells treated with Proscillaridin A 9.49
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 9.48
Gene expression analysis of immortalized human liver progenitor-like cells in culture 9.41
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 9.39
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 9.31
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 9.28
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 9.23
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 9.2
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 9.15
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 9.15
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 9.15
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 9.1
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 9.07
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 9.04
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 8.95
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 8.84
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 8.84
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 8.81
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 8.81
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 8.81
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 8.79
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 8.77
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 8.77
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 8.76
Global gene expression profile of dasatinib-resistant RCH-ACV cells 8.66
Global analysis of enhancer targets: Mosaic-seq 8.65
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 8.64
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 8.63
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 8.58
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 8.5
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 8.45
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 8.45
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 8.43
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 8.41
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 8.34
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 8.29
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 8.29
IDH3a KO RNA-seq 8.2
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 8.18
ETV7 and interferon response 8.18
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 8.18
Zone dependent distinctive gene expression profile of the normal human liver tissue 8.16
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 8.16
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 8.12
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 8.03
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 7.99
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 7.97
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 7.96
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 7.95
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 7.95
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 7.94
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 7.85
SLAM-seq for K562 endogenous mRNA decay 7.83
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 7.8
Gene expressions of H9s in different culture systems 7.74
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 7.72
Identification of HOXB13 target genes responsive to BET inhibitors 7.63
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 7.58
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 7.58
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 7.57
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 7.55
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 7.53
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 7.53
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 7.48
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 7.47
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 7.43
Genome wide expression change by RNF168 knocking down in NEC cells 7.38
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 7.38
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 7.38
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 7.37
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 7.37
Systematic discovery of endogenous human ribonucleoprotein complexes 7.35
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 7.33
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 7.32
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 7.32
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 7.32
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 7.28
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 7.27
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 7.27
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 7.23
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 7.18
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 7.17
Total RNA-seq in ALL-SIL upon TLX1 knockdown 7.14
scRNASeq analysis of cycling cardiomyocytes 7.12
The human blood-nerve barrier transcriptome 7.11
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 7.08
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 7.08
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 7.0
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 6.97
MeRIP-seq for heat shock in B-cell lymphoma cells 6.96
RNA-seq analysis of AML cells in response to ASLAN003 6.96
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 6.92
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 6.91
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 6.89
Identification of global regulators of T-helper cell lineage specification 6.89
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 6.89
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 6.88
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 6.86
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 6.84
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 6.79
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 6.79
AUF-1 affected genes in human skin cells 6.76
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 6.7
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 6.69
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 6.64
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 6.63
DART-seq: an antibody-free method for global m6A detection 6.63
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 6.61
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 6.56
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 6.46
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 6.43
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 6.4
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 6.38
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 6.35
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 6.29
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 6.29
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 6.28
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 6.28
A sister of NANOG regulates genes expressed in pre-implantation human development 6.26
Generating Patterned Kidney Organoids for Studying Development and Diseases 6.25
CD86 regulates a pro-survival signal in myeloma cells 6.21
CD73 knockdown effect in pancreatic cancer cell lines 6.2
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 6.17
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 6.16
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 6.14
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 6.14
Primary human trophoblast from term placenta 6.13
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 6.1
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 6.1
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 6.09
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 6.08
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 6.05
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 6.05
Transcriptome analysis of U87 cells upon LINC00152 knockdown 6.03
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 6.02
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 6.02
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 6.0
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 6.0
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 5.98
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 5.98
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.97
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 5.96
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 5.95
T47D RNA-seq and ChrRNA-seq data 5.95
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 5.95
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 5.94
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 5.93
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 5.9
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 5.88
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 5.86
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 5.8
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 5.75
Lysine benzoylation is a novel histone mark [RNA-seq] 5.74
Lysine benzoylation is a novel histone mark 5.74
Comprehensive comparative analysis of 5’ end RNA sequencing methods 5.62
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 5.58
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 5.57
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 5.57
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 5.56
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 5.51
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 5.5
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 5.49
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 5.48
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 5.45
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 5.45
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 5.45
Oncogenic MYC induces a dependency on the spliceosome in human cancer 5.42
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 5.38
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 5.38
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 5.37
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 5.35
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 5.35
Hypoxic transcriptome of SQ20B human head and neck cancer cells 5.28
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 5.24
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 5.16
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 5.15
Global transcriptome analysis of HAP1 cells 5.08
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 5.0
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 4.94
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 4.85
U1 snRNP telescripting regulates size-function stratified human genome 4.85
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 4.85
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 4.85
Identification of differentially expressed genes between senescence and senescence bypass cells 4.83
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 4.81
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 4.77
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 4.75
Differential Gene Expression between MCF10A and MCF7 cells 4.74
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 4.71
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 4.71
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 4.66
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 4.66
Human embryonic stem cells in E8 and AKIT culture medium 4.59
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 4.59
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 4.58
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 4.58
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 4.55
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 4.55
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 4.55
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 4.53
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 4.49
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 4.48
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 4.44
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 4.44
RNA seq comparison between scrambled and shGRP78 cells 4.41
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 4.39
Gene profiling of human adult and pediatric liver cancer cells 4.37
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 4.36
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 4.36
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 4.31
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 4.29
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 4.29
FBXW7 modulates stress response by post-translational modification of HSF1 4.29
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 4.29
RNA sequencing of mechanically strained NHEKs and control NHEKs 4.29
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 4.28
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 4.27
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 4.27
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 4.24
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 4.23
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 4.22
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 4.21
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 4.19
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 4.17
RNAseq of T-ALL upon long non coding rna purturbation 4.14
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 4.11
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 4.09
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 4.02
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 4.02
A20 regulates canonical wnt-signaling through an interaction with RIPK4 4.01
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 3.99
RNA sequencing of human mammary epithelial cells 3.95
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 3.94
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 3.93
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 3.93
Chromatin landscape of human visceral and subcutaneous adipocytes 3.9
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 3.9
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 3.86
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 3.86
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 3.85
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 3.79
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 3.72
Gene expression signatures of innate lymphoid cells from human blood 3.65
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 3.65
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 3.64
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 3.64
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.61
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 3.55
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 3.5
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.49
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 3.47
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 3.47
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 3.45
Gene expression changes due to PARP knockdown in human cells 3.42
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 3.41
Oncogenic roles of ARID5B in T-ALL 3.41
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 3.4
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 3.4
RNA seq with AML (NB4) cells upon FTO inhibition 3.37
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 3.31
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 3.31
RNA Seq of HMVEC under hypoxia 3.28
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 3.28
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 3.28
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 3.28
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 3.26
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 3.26
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 3.24
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 3.24
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 3.19
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 3.19
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 3.16
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 3.12
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 3.12
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 3.07
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 3.04
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 3.04
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 3.02
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 2.98
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 2.95
NAPRT activation of macrophages 2.95
H1609088 Human RNA-Sequencing 2.92
RNA-sequencing of healthy human skeletal myocytes 2.9
Single-cell analysis of human kidney organoids 2.88
MARCKS and lnc-MARCKS act as inflammation regulators 2.81
Positively selected enhancer elements endow tumor cells with metastatic competence 2.79
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.77
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 2.75
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.71
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 2.69
Human cells contain natural double-stranded RNAs with potential regulatory capacity 2.64
Genome-wide analysis of the Integrator complex (HTS) 2.64
Genome-wide analysis of the Integrator complex 2.64
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 2.59
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 2.57
Functional significance of the HIV-1 Tat signature amino acid residues 2.56
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 2.55
The cohesin complex prevents Myc-induced replication stress 2.55
RNA-seq of IL-4 stimulated human keratinocytes 2.54
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 2.53
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 2.53
A novel target of EZH1/2 for treatment of mantle cell lymphoma 2.51
MCF-7 as a model for functional analysis of breast cancer risk variants 2.5
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 2.48
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 2.47
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 2.47
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 2.43
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 2.38
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 2.38
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 2.37
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 2.37
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.35
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 2.3
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 2.3
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 2.24
Transcriptional profiling of LS1034 cells treated with tepoxalin 2.24
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.22
RNA-seq data 2.2
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 2.17
RNA-seq analysis upon ARID1B overexpression 2.13
The Genetic Landscape of Diamond-Blackfan Anemia 2.12
Transcriptome analysis of kidney organoids 2.11
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 2.1
6mer seed toxicity in viral microRNAs 2.08
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.06
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 2.0
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 1.99
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 1.99
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.95
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.92
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 1.91
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 1.81
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.78
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.74
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.67
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 1.66
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.64
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 1.64
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 1.6
O-glcnAc reprograms cellular energetics 1.59
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.58
Human Treg IL-12 stimulation 1.55
BET bromodomain inhibition 1.54
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 1.54
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.53
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 1.5
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 1.5
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.49
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 1.49
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 1.48
Impact on erythroid progenitor type on erythroid differntiation 1.46
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.44
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 1.43
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 1.43
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.41
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 1.41
RNA seq_PDX2_SHP099 1.4
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 1.35
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 1.26
Transcriptomic analysis of human tonsillar TFH subsets 1.25
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.21
Tracing Enhancer Networks using Epigenetic Traits (TENET) 1.16
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 1.15
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.14
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 1.14
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.1
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 1.06
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 1.05
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 1.03
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 1.02
RNA seq analysis of human Fetal and adult derived Enterospheres 0.95
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.9
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.85
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 0.84
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.8
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.8
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.78
RNA Sequencing of Human iPS derived Cardiomyocytes 0.75
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.74
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 0.73
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.71
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 0.69
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.68
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 0.66
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.66
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.62
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.62
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.56
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.55
Function and hormonal regulation of GATA3 in human first trimester placentation 0.54
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.54
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.53
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.5
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.5
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 0.46
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.45
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.44
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.42
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.38
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 0.37
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.34
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.34
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.33
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.32
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 0.3
EGR1-controlled transcriptome of T HESCs 0.28
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.28
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.25
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.24
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.24
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 0.23
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.2
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.19
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.18
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.14
Global transcriptome analysis of WT versus HEB-/- hESCs 0.13
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.12
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.12
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.12
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 0.08
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.08
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.05
Myc activation coordinates gene transcription and protein translation responses 0.05
SF3B1 Degron knockdown RNA-seq 0.05
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.02
Molecular analysis of renal cell carcinoma with unclassfied histology 0.02
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.02
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.02
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.02
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.01
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation